Molecular Diagnostics and Targeted Therapies for Breast and Prostate Cancers
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Biological Factors".
Deadline for manuscript submissions: 31 May 2026
Special Issue Editors
Interests: radiopharmaceuticals; molecular imaging; targeted therapy; theranostics
Interests: theranostics; radiopharmacy; molecular imaging; prostate cancer
Interests: radiopharmaceuticals; radiopeptides; radiopharmacy; preclinical evaluation; theranostics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in cancer biology have catalyzed the development of a new generation of anticancer therapies, particularly targeted therapies. Unlike conventional chemotherapeutic agents, targeted pharmaceuticals specifically guide the drugs to the malignant sites, utilizing specific molecular targets associated with tumors. These therapies offer the potential to improve treatment efficacy while minimizing off-target toxicity, thereby enhancing therapeutic outcomes and patient quality of life.
The development of reliable molecular diagnostic procedures is a key issue for the successful application of targeted therapy. Hence, it is of vital importance to develop accurate diagnostic methods to select and manage the treatment strategy, together with the development of new targeted anticancer drugs.
Breast and prostate cancers remain among the most prevalent malignancies worldwide, and their high incidence has spurred extensive research into their molecular underpinnings. Precise molecular diagnostics not only help to define the cancer subtype and stage but also guide therapeutic decision-making, ultimately improving patient prognosis.
In this Special Issue, the focus will be on the development of new diagnostic and therapeutic agents targeting well-established and emerging cancer-associated molecular targets, specifically, but not limited to, prostate and breast cancers. The development of diagnostic agents for different modalities and therapeutic drugs with varying mechanisms of action has the potential to refine personalized cancer care and improve clinical outcomes for patients.
We look forward to receiving your contributions.
Prof. Dr. Anna Orlova
Dr. Ekaterina Bezverkhniaia
Dr. Panagiotis Kanellopoulos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular imaging
- targeted therapy
- prostate cancer
- breast cancer
- theranostics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
